1. Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population- Based Cohort Study 
Brenda C.T. Kieboom, MD, Jessica C. Kiefte–de Jong, RD, PhD, Mark Eijgelsheim, MD, PhD, Oscar H. Franco, MD, PhD, Ernst J. Kuipers, MD, PhD, Albert Hofman, MD, PhD, Robert Zietse, MD, PhD, Bruno H. Stricker, MMed, PhD, Ewout J. Hoorn, MD, PhD 
American Journal of Kidney Diseases 
Volume 66, Issue 5, Pages (November 2015)
DOI: /j.ajkd
Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Distribution of serum magnesium levels among participants not using acid-suppressive medication, and participants who used proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs). PPI users and H2RA users more often had a serum magnesium level in the lowest quartile.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions